Editorial: Advances in chemotherapy-resistant hepatocellular carcinoma, volume II

Editorial: Advances in chemotherapy-resistant hepatocellular carcinoma, volume II

Saved in:

Bibliographic Details
Main Authors:	Shui Liu, Yufan Liu, Mo Sha, Yang Li, Jiyao Sheng
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-03-01
Series:	Frontiers in Medicine
Subjects:	hepatocellular carcinoma chemotherapy chemoresistance individualized therapy chemoresistance mechanisms cholangiocarcinoma
Online Access:	https://www.frontiersin.org/articles/10.3389/fmed.2025.1594854/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Misdiagnosis and Chemotherapy Delaying Reduces the Chemosensitivity of Choriocarcinoma Patient: Analysis of 36 Cases
by: Lin-Jing Yuan, et al.
Published: (2022-07-01)

DCAF7 Acts as A Scaffold to Recruit USP10 for G3BP1 Deubiquitylation and Facilitates Chemoresistance and Metastasis in Nasopharyngeal Carcinoma
by: Qing‐Jie Li, et al.
Published: (2024-09-01)

Targeting GPX4 to Induce Ferroptosis Overcomes Chemoresistance Mediated by the PAX8‐AS1/GPX4 Axis in Intrahepatic Cholangiocarcinoma
by: Zhi‐Wen Chen, et al.
Published: (2025-08-01)

Extracellular matrix production and oxygen diffusion regulate chemotherapeutic response in osteosarcoma spheroids
by: Isabel S. Sagheb, et al.
Published: (2024-09-01)

The human microbiome: redefining cancer pathogenesis and therapy
by: Yogita K. Adlakha, et al.
Published: (2025-04-01)

The interplay between COX-2, chemotherapeutic drugs, and chemoresistance in colon cancer
by: Sally M. Shalaby, et al.
Published: (2025-05-01)

ASSESSMENT OF RECEPTOR CONVERSION ROLE FOR ADVANCED BREAST CANCER ON THE CHEMORESISTANCE OCCURRENCE
by: Oleksii V. Movchan, et al.
Published: (2025-03-01)

Chemoresistance factors in non-small cell lung cancer
by: А. I. Shevchenko, et al.
Published: (2016-04-01)

Changes in the expression of genes that regulate apoptosis as a factor in the development of chemoresistance in soft tissue sarcoma
by: T. I. Fetisov, et al.
Published: (2024-12-01)

Clinical cases of management and treatment of women with chemoresistant tuberculosis during pregnancy
by: O. M. Raznatovska, et al.
Published: (2020-07-01)

Features and complexity of treatment of <i>BRCA</i>-associated ovarian cancer, chronic disease: literature review
by: T. V. Gorodnova, et al.
Published: (2024-11-01)

Ferroptosis in cancer: revealing the multifaceted functions of mitochondria
by: Xinyi Ding, et al.
Published: (2025-07-01)

Dimethyl fumarate abrogates hepatocellular carcinoma growth by inhibiting Nrf2/Bcl-xL axis and enhances sorafenib’s efficacy
by: Oluwasijibomi Damola Faleti, et al.
Published: (2025-05-01)

Inhibition of Selenoprotein I promotes ferroptosis and reverses resistance to platinum chemotherapy by impairing Akt phosphorylation in ovarian cancer
by: Jing Li, et al.
Published: (2024-12-01)

Aquaglyceroporin-7 ameliorates sorafenib resistance and immune evasion in hepatocellular carcinoma through inhibition of lipid accumulation
by: Guangsi He, et al.
Published: (2025-07-01)

Development of a prognostic model for chemotherapy response and identification of TNFAIP2 as a target in colorectal cancer
by: Cheng Zhou, et al.
Published: (2025-06-01)

DNA-methylation eraser TET2 activates WTIP expression to suppress an AKT-dependent chemoresistance of gastric cancer
by: Yan Guo, et al.
Published: (2025-07-01)

Overcoming temozolomide resistance in glioma: recent advances and mechanistic insights
by: Hengzeng Li, et al.
Published: (2025-06-01)

Warburg effect and lactylation in cancer: mechanisms for chemoresistance
by: Wenjie Zhang, et al.
Published: (2025-04-01)

WBP1 regulates mitochondrial function and ferroptosis to modulate chemoresistance in colorectal cancer
by: Yang Wang, et al.
Published: (2025-03-01)

The Role of V-ATPase ATP6V0D1 Subunit in Chemoresistance and Ellipticine-Induced Cytoplasmic Vacuolation in Neuroblastoma Cells
by: M Rychla, et al.
Published: (2025-12-01)

Ascitis as a unique microenvironment of tumors in ovarian cancer: interaction with prognosis and chemoresistance
by: A. B. Villert, et al.
Published: (2019-07-01)

THE IMPACT OF RAD6 EXPRESSION ON CHEMORESISTANT OVARIAN CANCER: A SYSTEMATIC REVIEW
by: Leo Vernadesly, et al.
Published: (2025-01-01)

Clinical case of chemoresistant tuberculosis in the patient with tuberous sclerosis: difficulties of diagnosis, features of the course and treatment.
by: N. S. Kolesnik, et al.
Published: (2019-12-01)

Peculiarities of chemo-resistant HIV/AIDS-associated tuberculosis in patients who died from co-infection
by: A. S. Shalmin, et al.
Published: (2013-04-01)

Development and validation of a predictive score for chemoresistance in high-grade osteosarcoma at baseline
by: Thanat Kanthawang, et al.
Published: (2025-07-01)

Unraveling the role of long non-coding RNAs in therapeutic resistance in acute myeloid leukemia: New prospects & challenges
by: Siddhant Sharma
Published: (2024-12-01)

Reversal of chemotherapy resistance in gastric cancer with traditional Chinese medicine as sensitizer: potential mechanism of action
by: Chencong Zhou, et al.
Published: (2025-02-01)

GPX3 promotes cisplatin resistance in TNBC by manipulating ROS-TGFB1-ZEB2
by: Qingyi Hu, et al.
Published: (2025-07-01)

Characterization of lysine crotonylation-related lncRNAs for prognostic assessment and immune response in glioma
by: Miaomiao Song, et al.
Published: (2025-06-01)

5-methylcytosine regulated CCNL2 promotes tumorigenesis and cisplatin resistance of ovarian cancer with therapeutic implications
by: Kai Zhang, et al.
Published: (2025-07-01)

Restriction of YWHAB-mediated YAP cytoplasmic retention is a novel mechanism underlying stemness maintenance and chemoresistance in ovarian cancer peritoneal metastasis
by: Chang Liu, et al.
Published: (2025-09-01)

A Dual Approach with Organoid and CRISPR Screening Reveals ERCC6 as a Determinant of Cisplatin Resistance in Osteosarcoma
by: Ruiling Xu, et al.
Published: (2025-07-01)

Features of endobronchial pathology among patients with chemoresistant tuberculosis of lungs depending on a case of the previous disease
by: O. M. Raznatovska, et al.
Published: (2017-08-01)

Extracellular vesicles from human breast cancer-resistant cells promote acquired drug resistance and pro-inflammatory macrophage response
by: Patrick Santos, et al.
Published: (2024-10-01)

OTULIN confers cisplatin resistance in osteosarcoma by mediating GPX4 protein homeostasis to evade the mitochondrial apoptotic pathway
by: Zehang Zheng, et al.
Published: (2024-12-01)

Xanthatin nanocrystals exert anti-inflammatory properties against TNFα-primed 2D monolayers and in 3D spheroids of human HT29 colorectal cancer cells
by: Aleksandra Berenguer Roque, et al.
Published: (2025-05-01)

Serum Hsa_circ_0023919 is a Predictive Biomarker of Chemoresistance in CRC Treatment
by: Zhang L, et al.
Published: (2024-12-01)

GDF-15 upregulates the SLC7A11/GPX4 signaling axis and promotes mitoxantrone resistance in AML cells
by: Qian-wei Lu, et al.
Published: (2025-06-01)

Unlocking the secret of glioblastoma multiforme: the role of lactylation in tumor progression, drug resistance and immune microenvironment
by: Yifei Xiao, et al.
Published: (2025-08-01)